Amgen AMGN Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amgen's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amgen's deferred tax assets and other non-current assets?
- Amgen (AMGN) reported deferred tax assets and other non-current assets of $12.76B in Q1 2026.
- How has Amgen's deferred tax assets and other non-current assets changed year-over-year?
- Amgen's deferred tax assets and other non-current assets increased by 12.0% year-over-year, from $11.39B to $12.76B.
- What is the long-term trend for Amgen's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Amgen's deferred tax assets and other non-current assets has grown at a 17.6% compound annual growth rate (CAGR), from $5.64B to $12.66B.